Baker Bros. Advisors LP Edgewise Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $7.9 Billion
- Q1 2024
A detailed history of Baker Bros. Advisors LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 5,840,059 shares of EWTX stock, worth $105 Million. This represents 1.35% of its overall portfolio holdings.
Number of Shares
5,840,059
Previous 3,112,786
87.62%
Holding current value
$105 Million
Previous $34.1 Million
212.81%
% of portfolio
1.35%
Previous 0.4%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
129Shares Held
76.3MCall Options Held
14.7KPut Options Held
14.8K-
Orbimed Advisors LLC San Diego, CA15MShares$271 Million6.17% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$93.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$72.4 Million0.0% of portfolio
-
Viking Global Investors LP3.34MShares$60.1 Million0.23% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.3MShares$59.5 Million3.16% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.14B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...